FDA approved Miltenyi Biotec's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.
The Susan G. Komen Breast Cancer Foundation reported a 22 percent decline in contributions in fiscal 2013—totalling over $77 million—in recent financial statements.
The Community Oncology Alliance and the American Society of Clinical Oncology issued a joint statement on payment reform in cancer care and proposed alternative approaches to paying for cancer care.
The American Cancer Society has started a search to replace its chief executive officer, John Seffrin.
The rate of new lung cancer cases decreased among men and women from 2005 to 2009, largely due to tobacco control efforts, according to a report from the Centers for Disease Control and Prevention.
Congress has passed a $1.012 trillion omnibus spending bill, easing the sequestration cuts set for fiscal 2014 and keeping the government open through September. President Barack Obama is expected to sign the bill by Saturday.
In another round of changes in the executive suite at MD Anderson Cancer Center, Dan Fontaine was appointed head the institutional advancement division, President Ronald DePinho announced in an email to the faculty and staff.
When surveyed by the Faculty Senate in October 2012, nearly a third of faculty members at MD Anderson Cancer Center who responded said they were likely to leave the institution within three years.
FDA granted accelerated approval for Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for unresectable melanoma or metastatic melanoma with BRAF V600E or V600K mutations.
Declines in death rates over past two decades have added up to a 20 percent drop in the overall risk of dying from cancer, according to the American Cancer Society's annual statistics report.
